Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Net Cash Flow (2010 - 2025)

Grifols' (GIFLF) quarterly Net Cash Flow came in at -$1.3 billion in Q4 2025, up 11.19% on a YoY basis from -$1.2 billion in Q4 2024, and up 11.19% quarter-over-quarter from -$1.5 billion in Q4 2024.

Analysis

Grifols (GIFLF) Net Cash Flow (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Net Cash Flow for 15 consecutive years, with -$1.3 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 11.19% year-over-year to -$1.3 billion; the trailing twelve-month figure through Dec 2025 stood at -$5.4 billion (down 27.52% YoY), and the FY2025 full-year result was -$68.9 million, down 115.03% from the prior year.
  • Net Cash Flow improved to -$1.3 billion in Q4 2025 per GIFLF's latest filing, from -$1.5 billion in the prior quarter.
  • Across five years, Net Cash Flow topped out at -$423.9 million in Q4 2023 and bottomed at -$2.2 billion in Q4 2022.
  • Historically, Net Cash Flow has averaged -$1.3 billion across 4 years, with a median of -$1.4 billion in 2024.
  • The sharpest annual moves came in 2023 and 2024: Net Cash Flow jumped 80.79% in 2023, then plunged 242.57% in 2024.
  • Over 4 years, Net Cash Flow stood at -$2.2 billion in 2022, then surged by 80.79% to -$423.9 million in 2023, then slumped by 242.57% to -$1.5 billion in 2024, then grew by 11.19% to -$1.3 billion in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$1.3 billion, -$1.5 billion, and -$423.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -496,000.00
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -170.75 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -1.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.29 Bn
Dec 31, 2024 -1.45 Bn
Dec 31, 2023 -423.92 Mn
Dec 31, 2022 -2.21 Bn
Mar 31, 2020 -130.24 Mn
Dec 31, 2019 -324.92 Mn
Mar 31, 2019 -541.80 Mn
Dec 31, 2018 1.31 Bn
Jun 30, 2018 -530.10 Mn
Mar 31, 2018 249.20 Mn
Dec 31, 2017 4.86 Bn
Jun 30, 2017 247.39 Mn
Mar 31, 2017 3.80 Bn
Dec 31, 2016 -72.03 Mn
Sep 30, 2016 -604.20 Mn
Dec 31, 2015 -1.29 Bn
Sep 30, 2015 271.26 Mn
Jun 30, 2015 1.43 Bn
Mar 31, 2015 -461.73 Mn
Dec 31, 2014 389.16 Mn